Officiële publicaties AbbVie Inc. London S.E.

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:30:00 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
163,1 ^USD	+0,96%		+1,78%	+5,51%

30/04	Alvotech gaat Humira Biosimilar Adalimumab-ryvk maken voor Quallent	MT
29/04	ABBVIE INC. : BMO Capital bevestigt koopadvies	ZM

1st quarter results	26/04	CO
SEC Filing 8K	26/04	CO
SEC Filing 10K	20/02	CO
Annual results	02/02	CO
SEC Filing 8K	02/02	CO
SEC Filing 13G	25/01	CO
SEC Filing 8K	05/01	CO
SEC Filing 10Q-3	06/11	CO
3rd quarter results	27-10-23	CO
SEC Filing 8K	27-10-23	CO
SEC Filing 8K	12-10-23	CO
SEC Filing 8K	04-10-23	CO
SEC Filing 10Q-2	07-08-23	CO
1st-half-year results	27-07-23	CO
SEC Filing 8K	27-07-23	CO
SEC Filing 4K	12-05-23	CO
SEC Filing 8K	10-05-23	CO
SEC Filing 4K	09-05-23	CO
Shareholders meeting voting results	05-05-23	CO
SEC Filing 10Q-1	05-05-23	CO
SEC Filing 4K	05-05-23	CO
SEC Filing 4K	05-05-23	CO
SEC Filing 4K	05-05-23	CO
SEC Filing 4K	05-05-23	CO
SEC Filing 4K	05-05-23	CO